LifeMD ROA 2011-2024 | LFMD
Current and historical return on assets (ROA) values for LifeMD (LFMD) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| LifeMD ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-06-30 | $-0.03B | $0.06B | -50.00% |
| 2024-03-31 | $-0.03B | $0.06B | -57.44% |
| 2023-12-31 | $-0.03B | $0.06B | -59.52% |
| 2023-09-30 | $-0.03B | $0.04B | -97.06% |
| 2023-06-30 | $-0.03B | $0.04B | -106.25% |
| 2023-03-31 | $-0.04B | $0.03B | -122.14% |
| 2022-12-31 | $-0.05B | $0.03B | -133.33% |
| 2022-09-30 | $-0.06B | $0.03B | -128.65% |
| 2022-06-30 | $-0.06B | $0.04B | -158.44% |
| 2022-03-31 | $-0.06B | $0.05B | -182.86% |
| 2021-12-31 | $-0.06B | $0.05B | -227.52% |
| 2021-09-30 | $-0.08B | $0.02B | -422.22% |
| 2021-06-30 | $-0.09B | $0.02B | -563.93% |
| 2021-03-31 | $-0.07B | $0.02B | -720.00% |
| 2020-12-31 | $-0.06B | $0.01B | -1078.26% |
| 2020-09-30 | $-0.03B | $0.01B | -923.08% |
| 2020-06-30 | $-0.01B | $0.00B | -254.55% |
| 2020-03-31 | $-0.01B | $0.00B | -200.00% |
| 2019-12-31 | $-0.00B | $0.00B | -145.45% |
| 2019-09-30 | $-0.00B | $0.00B | -109.09% |
| 2019-06-30 | $-0.00B | $0.00B | -120.00% |
| 2019-03-31 | $-0.00B | $0.00B | -120.00% |
| 2018-12-31 | $-0.00B | $0.00B | -50.00% |
| 2018-09-30 | $-0.00B | $0.00B | -66.67% |
| 2018-06-30 | $-0.00B | $0.00B | -80.00% |
| 2018-03-31 | $0.00B | $0.00B | 100.00% |
| 2017-12-31 | $-0.00B | $0.00B | -100.00% |
| 2017-09-30 | $-0.00B | $0.00B | -200.00% |
| 2017-06-30 | $-0.00B | $0.00B | -100.00% |
| 2017-03-31 | $-0.00B | $0.00B | -200.00% |
| 2016-12-31 | $-0.00B | $0.00B | -100.00% |
| 2016-09-30 | $0.00B | $0.00B | 0.00% |
| 2016-06-30 | $0.00B | $0.00B | 0.00% |
| 2016-03-31 | $0.00B | $0.00B | 0.00% |
| 2015-12-31 | $0.00B | $0.00B | nan% |
| 2015-09-30 | $0.00B | $0.00B | nan% |
| 2015-06-30 | $0.00B | $0.00B | nan% |
| 2015-03-31 | $0.00B | $0.00B | nan% |
| 2014-12-31 | $0.00B | $0.00B | nan% |
| 2014-09-30 | $0.00B | $0.00B | 0.00% |
| 2014-06-30 | $0.00B | $0.00B | 0.00% |
| 2014-03-31 | $0.00B | $0.00B | 0.00% |
| 2013-12-31 | $0.00B | $0.00B | 0.00% |
| 2013-09-30 | $0.00B | $0.00B | nan% |
| 2013-06-30 | $0.00B | $0.00B | nan% |
| 2013-03-31 | $0.00B | $0.00B | nan% |
| 2012-12-31 | $0.00B | $0.00B | nan% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.186B | $0.153B |
| LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $95.221B | 11.81 |
| Cencora (COR) | United States | $45.670B | 17.45 |
| DiDi Global (DIDIY) | China | $24.521B | 0.00 |
| ICON (ICLR) | Ireland | $19.172B | 17.08 |
| Natera (NTRA) | United States | $15.428B | 0.00 |
| Avantor (AVTR) | United States | $15.327B | 22.98 |
| Revvity (RVTY) | United States | $14.524B | 25.43 |
| Viatris (VTRS) | United States | $14.013B | 4.27 |
| BioMerieux (BMXMF) | France | $13.361B | 0.00 |
| Solventum (SOLV) | United States | $12.668B | 0.00 |
| CochLear (CHEOY) | Australia | $12.218B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.249B | 28.88 |
| Charles River Laboratories (CRL) | United States | $9.500B | 17.95 |
| Sonic Healthcare (SKHHY) | Australia | $8.345B | 0.00 |
| Doximity (DOCS) | United States | $7.775B | 49.27 |
| HealthEquity (HQY) | United States | $7.607B | 41.28 |
| Bausch + Lomb (BLCO) | Canada | $7.309B | 31.45 |
| PACS (PACS) | United States | $6.436B | 0.00 |
| Life Times (LTH) | United States | $4.709B | 31.16 |
| Organon (OGN) | United States | $4.596B | 4.67 |
| Sotera Health (SHC) | United States | $4.509B | 22.74 |
| Surgery Partners (SGRY) | United States | $3.821B | 42.34 |
| BrightSpring Health Services (BTSG) | United States | $2.728B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.670B | 0.00 |
| Concentras Parent (CON) | United States | $2.561B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.432B | 91.57 |
| GeneDx Holdings (WGS) | United States | $2.263B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.240B | 0.00 |
| Premier (PINC) | United States | $2.020B | 9.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.922B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.540B | 7.73 |
| Teladoc Health (TDOC) | United States | $1.527B | 0.00 |
| Progyny (PGNY) | United States | $1.412B | 24.83 |
| Establishment Labs Holdings (ESTA) | $1.253B | 0.00 | |
| CareDx (CDNA) | United States | $1.192B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.114B | 12.12 |
| Agilon Health (AGL) | United States | $1.037B | 0.00 |
| Embecta (EMBC) | United States | $0.835B | 5.57 |
| InnovAge Holding (INNV) | United States | $0.799B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.727B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.479B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.425B | 0.00 |
| DocGo (DCGO) | United States | $0.356B | 13.39 |
| Enhabit (EHAB) | United States | $0.351B | 30.35 |
| Biodesix (BDSX) | United States | $0.240B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.236B | 0.00 |
| Beauty Health (SKIN) | United States | $0.222B | 0.00 |
| ModivCare (MODV) | United States | $0.220B | 7.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.176B | 0.00 |
| MultiPlan (MPLN) | United States | $0.161B | 0.00 |
| Nutex Health (NUTX) | United States | $0.112B | 0.00 |
| So-Young (SY) | China | $0.099B | 24.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.060B | 0.00 |
| OncoCyte (OCX) | United States | $0.052B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.65 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.034B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.024B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |